Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

NCT: NCT05276050 · RECRUITING

NCT IDNCT05276050
StatusRECRUITING
Start Date2022-06-01
Completion2028-02-14
SponsorThe University of Texas Health Science Center, Houston (OTHER)
First posted
Last updated

Brief Summary

Patients with schizophrenia spectrum disorder (SSD) will be exposed to active repetitive transcranial magnetic stimulation (rTMS) from F8 coil or active rTMS from H coil for smoking cessation. Smoking and brain functional connectivity changes will be assessed at baseline, different stages of rTMS and/or follow-ups.

Frequently Asked Questions

What is Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)?

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3) is a clinical trial registered under NCT05276050. Current status: RECRUITING.

What is the status of NCT05276050?

The current status of NCT05276050 (Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)) is: RECRUITING.

When did Circuitry-Guided Smoking Cessation in Schizophrenia (UH3) start?

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3) started on 2022-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑